Understanding Value Stocks
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Cross Country Healthcare (NASDAQ:CCRN) – P/E: 7.23
- Nuwellis (NASDAQ:NUWE) – P/E: 0.02
- First Wave BioPharma (NASDAQ:FWBI) – P/E: 0.01
- Voyager Therapeutics (NASDAQ:VYGR) – P/E: 6.69
- Panbela Therapeutics (NASDAQ:PBLA) – P/E: 0.0
Most recently, Cross Country Healthcare reported earnings per share at $0.39, whereas in Q2 earnings per share sat at $0.69. Nuwellis’s earnings per share for Q3 sits at $-1.81, whereas in Q2, they were at -3.65. First Wave BioPharma’s earnings per share for Q3 sits at $-0.46, whereas in Q2, they were at -1.89. Voyager Therapeutics’s earnings per share for Q3 sits at $-0.59, whereas in Q2, they were at -0.51. Panbela Therapeutics saw an increase in earnings per share from -7.95 in Q2 to $-2.42 now.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
